Comprehensive Therapy

, Volume 32, Issue 3, pp 182–188

Use of antiplatelet drugs in secondary prevention in patients with atherothrombotic disease

Authors

    • Cardiology DivisionNew York Medical Colleg
    • Division of of Geriatrics, Department of MedicineWestchester Medical Center/ New York Medical College
    • Division of Pulmonary/Critical Care Medicine, Department of MedicineWestchester Medical Center/ New York Medical College
Original Article

DOI: 10.1007/s12019-006-0010-9

Cite this article as:
Aronow, W.S. Compr Ther (2006) 32: 182. doi:10.1007/s12019-006-0010-9

Abstract

Unless there are contraindications to the use of aspirin, aspirin should be used to treat patients with acute myocardial infarction (MI) and continued indefinitely to decrease vascular death, nonfatal MI, and nonfatal stroke. Chlopidogrel added to aspirin is beneficial in the treatment of patients with acute ST-elevation MI. Patients with unstable angina pectoris or non-ST-elevation MI should be treated with aspirin plus clopindogrel for at least 9 mo to decease vascular death, nonfatal MI, and nonfatal stroke. Patients with prior MI should be treated indefinitely with aspirin and with clopidogrel if aspirin is contraindicated. Patients with ischemic stroke should be treated with either aspirin or clopidogrel indefinitely. Clopidogrel is significantly more effective than aspirin in reducing vascular death, nonfatal MI, and nonfatal stroke in patients with peripheral arterial disease

Copyright information

© ASCMS 2006